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Monday, February 27, 2012 307acorresponding to the peptide A binding site. We tested the effect of beta scor-
pion toxins - having a similar structure - on the RyR1 function. Charibdotoxin
(CHTX) elicits close state at 20 nM in an all or none and voltage dependent
manner because of smaller surface charge. Smaller size makes it easier to
reach the most inner toxin binding site (out of the three) which causes the clo-
sure of the channel. MCa and CHTX share a common binding site which is
identical to the peptide A binding site. Noxiustoxin has a similar effect at
slightly higher toxin concentration. At nanomolar concentration Kaliotoxin
evokes ‘‘flickering’’ of the channel in subconductance state which is occasion-
ally interrupted by long lasting closed states, while locks the channel in closed
state at micromolar concentration. Iberiotoxin induces a slight increase of the
open probability accompanied by normal gating while Slotoxin has no effect.
With the exception of MCa all toxins are effective only at one side, at the pre-
ferred side. Iberiotoxin and Slotoxin - ion spite of similar structure - have no
large positive surfaces, they exhibit random surface charge distribution. A
model has been proposed for the possible mode of action which accounts
for the above effect of the tested toxins. Supported by Hungarian Research
Found OTKA 81923.
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Penaresins and eudistomins are bioactive metabolites from marine organisms
that were found to induce Ca2þ release from skeletal muscle sarcoplasmic re-
ticulum (SkMSR). As these compounds could have characteristics of supercaf-
feines, we have carried out studies to contrast their ability to modulate RyRs
versus that of caffeine. Two eudistomin D derivatives were tested: bromoeudis-
tomin D (BED) and its putatively more potent analog N-methylbromoeudisto-
min D (MBED). We also tested penaresin (PE) and four PE analogs: N-methyl-
PE (MPE), nitro-PE (NPE), dicyano-PE (DCPE), and N-methyl-PE-methyl-
ester (MPEM). We utilized rabbit SkMSR microsomes to evaluate the effect
of penaresins and eudistomins on RyRs by measuring a) rates of Ca2þ loading
and Ca2þ release and b) [3H] ryanodine binding. We also tested the effects of
all the compounds on the activity of sarcoplasmic reticulum Ca2þ ATP-ase
(SERCA). We found that BED and MBED mimic caffeine in the capacity to
activate RyRs. At the doses required to fully activate RyRs, BED also inhibited
SERCA while MBED did not affect it. In our hands, penaresins were weaker
RyRs agonists and only partially matched the action of caffeine (at very high
concentrations, close to the drugs limit of solubility). Regarding the effects
on SERCA activity, PE was inhibitory whileMPEM displayed apparent agonis-
tic action. MBED, the most potent RyRs agonist, mimicked the reversible ac-
tion of caffeine on the open probability and gating kinetics of RyRs
reconstituted into planar lipid bilayers. Confocal microscopy studies are under-
way to compare the ability of these compounds versus caffeine to induce SR
calcium release in myocytes. In principle, our studies indicate that eudistomins
(especially MBED), but not penaresins, are potent ‘‘caffeine-like’’ agonists of
RyRs (supported by NIH RO1 GMO78665).
1565-Pos Board B335
Downstream Effects of a RyR1 Mutation Linked to Malignant Hyperther-
mia on the Phenotypic and Functional Characteristic of Dendritic Cells
Mirko Vukcevic1, Francesco Zorzato1,2, Susan Treves1,2.
1Departments of Anaesthesia and Biomedicine, Basel University Hospital,
Basel, Switzerland, 2Department of Experimental and Diagnostic Medicine,
General Pathology section, University of Ferrara, Ferrara, Italy.
The skeletal muscle ryanodine receptor 1 (RyR1) isoform is not only ex-
pressed in skeletal muscle, but also in immune cells, particularly in B lym-
phocytes and dendritic cells where it is involved in maturation and antigen
presentation. This implies that mutations causing gain of function of RyR1
may have an effect not only on skeletal muscle but also on the signaling
event leading to activation of immune response via antigen presenting cells
expressing RyR1. We investigated the phenotype and function of dendritic
cells obtained from the Y522S RYR1 knock in mouse, an animal model car-
rying a mutation linked to Malignant Hyperthermia. We show that CD11c
‘‘þve’’ cells isolated from spleens of WT and HET RYR1Y522S knock in
mice express RyR1 and that there is a significant increase in the surface ex-
pression of the maturation marker CD83 in MHCII positive dendritic cells
from RYR1Y522S mice compared to their wild type littermates. The increase
in dendritic cell maturation markers was linked to a significant increase in the
% CD4 þve T helper cells in the splenic cell population. We also investi-
gated whether the presence of the RYR1 mutation affects the capacity of den-dritic cells to activate T-cells. Mixed lymphocyte reactions between dendritic
cells from WT or RYR1Y522S mice with the Bl6 background and T-cells iso-
lated from Balb-c mice show that dendritic cells carrying the Y522S RYR1
mutation have an increased capacity to stimulate T cells. Based on the pres-
ent results we suggest that the presence of RYR1 mutations will not only af-
fect muscles, but will also affect the functional properties of the immune
system.
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When reconstituted into planar lipid bilayers, ryanodine receptors (RyRs) from
skeletal muscle sarcoplasmic reticulum (SR) display coupled gating, i.e. syn-
chronous opening/closures. Coupled gating was observed in ~20% of reconsti-
tutions after ATP/Mg2þ were added to the cytosolic solution. In the absence of
ATP/Mg2þ coupled gating was not evident in 20-90 min recordings from hun-
dreds of multichannel reconstitutions. ATP can be partially replaced by other
nucleotides (e.g. ADP, AMP) and does not appear to exert its modulatory action
through RyR1 phosphorylation. Agent that affect cytoskeleton did not impair
coupling. Luminal Ca2þ was also found to be crucial for finding coupled gat-
ing. Although a hypothetical participation of local Ca2þ-induced Ca2þ release
in the coupling phenomenon cannot completely be ruled out, direct luminal ef-
fects of Ca2þ on RyR1 seem to be key for RyR1 coupling. Coupled gating of
RyR1 was not affected by FKBP12 addition or removal (by long term exposure
to rapamycin). In some recordings, periods of coupled gating (seconds to min-
utes) are intercalated with periods of uncoupled events suggesting that revers-
ible changes in the gating status of interacting RyRs could be important for
coupling. In this regard, coupled gating was triggered by agonists (caffeine,
menthol and halothane) and was impaired by high Mg2þ or tetracaine, all
know to affect RyR gating status. We believe that coupled gating results
from physical interactions (possibly of electrostatic nature) between two clas-
ses of RyRs. This heterogeneity of RyRs is reflected both in their gating and
conductance. In summary, in the cellular environment coupling would be
highly dependent on ATP/Mg2þ levels and SR Ca2þ load (supported by
NIH RO1 GMO78665).
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We investigated Ca2þ signaling in cardiomyocytes from transgenic mice with
a mutation in the calmodulin (CaM) binding domain of RyR2 (W3587A/
L3591D/F3603A, RyR2ADA; Yamaguchi et al., Circ Res, 100:293-5,
2007). Ca2þ sparks (Fluo-4) in cardiomyocytes from 11-15 day old homozy-
gous mutant mice were less frequent (0.2650.17 vs. 3.6250.54 sparks/sec
n=18), but longer lasting than in wild-type. Voltage-clamp depolarization of
the mutant cells produced Ca2þ transients of reduced amplitude even though
those triggered by caffeine were enhanced and accompanied by disproportion-
ally larger Naþ-Ca2þ exchanger (NCX) currents. The distributions of RyR2,
NCX and membrane staining in mutant cells indicate a disorganized t-tubular
system. During repeated voltage-clamp depolarizations, mutant cardiomyo-
cytes produced alternans or gradually rising Ca2þ transients that in time de-
veloped a tendency to generate large delayed Ca2þ releases and NCX
currents thereby restarting the sequence. Our findings suggest that the expres-
sion RyR2ADA in homozygous mice with cardiac hypertrophy is associated
with impaired ICa-induced Ca2þ release resulting, In part, from disruption
of the t-tubular system and its associated dyadic junctions. At the same
time it is noticeable that the (partially decoupled) SR Ca2þ stores are well
maintained and produce a) infrequent, but long lasting Ca2þ sparks, and b)
large regenerative Ca2þ transients that are accompanied by prominent
NCX currents and can be triggered, not only by caffeine, but also by repeated
stimulation. The latter observation suggest a mechanism for delayed after-
depolarization, where the arrhythmogenic potential of NCX currents is en-
hanced by the concurrence of a number of factors: a) impaired Ca2þ signal-
ing by RyR2, b) partial structural decoupling of components of the SR Ca2þ
stores, and c) gradual enhancement of the Ca2þ contents of these stores re-
sulting e.g. from rapid beating during adrenergic stimulation. (NIH
HL16152; AHA 10SDG3500001).
